Valion Bio, Inc.

Valion Bio, Inc. financial statements

Valion Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 382KEODHD
Net income−USD 8.88M10-K
Cash and equivalentsUSD 12.64M10-Q
Total debtUSD 6.45MEODHD

Valion Bio, Inc. financials on 6ix · Valion Bio, Inc. on 6ix